EQL Pharma AB (EQL.ST) Q4 2024 Earnings

6NovConfirmed
Q4 2024
0.23
0.27
0.31
0.35

Details

Expected EPS
0.2309599908
Actual EPS
0.3464399862
Surprise EPS
0.12
Surprise Percent
+50%

Description

EQL Pharma AB (EQL.ST) has reported earnings of 0.3464399862 per share for Q4 2024.

0 Comments

Share your thoughts